Thyroid hormone and the cardiovascular system.
暂无分享,去创建一个
[1] C. Glass,et al. Coactivator and corepressor complexes in nuclear receptor function. , 1999, Current opinion in genetics & development.
[2] F I Gilbert,et al. Graves' disease. Influence of age on clinical findings. , 1988, Archives of internal medicine.
[3] D. Cooper,et al. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.
[4] R. D'Agostino,et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.
[5] L. Braverman,et al. The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.
[6] Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.
[7] G S Levey,et al. Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.
[8] A. Toft,et al. Left ventricular performance in subclinical hypothyroidism. , 1985, The Quarterly journal of medicine.
[9] S. Nekolla,et al. Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. , 2000, The Journal of clinical endocrinology and metabolism.
[10] P. Agostoni,et al. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. , 1996, The American journal of medicine.
[11] M. Lazar. Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.
[12] S. Homma,et al. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. , 1999, The Journal of thoracic and cardiovascular surgery.
[13] S. Padayatty. Concerning minimal cardiac effects in asymptomatic athyreotic patients treated with thyrotropin-suppressive doses of L-thyroxine. , 1998, The Journal of clinical endocrinology and metabolism.
[14] I. Klein,et al. Thyroid hormone therapy in cardiovascular disease. , 1996, Progress in cardiovascular diseases.
[15] F. Epstein,et al. The molecular basis of thyroid hormone action. , 1994, The New England journal of medicine.
[16] K. Ellenbogen,et al. The management of atrial fibrillation. , 1996, The American journal of medicine.
[17] F. B. Davis,et al. Acute cellular actions of thyroid hormone and myocardial function. , 1993, The Annals of thoracic surgery.
[18] E. Kranias,et al. Phospholamban: a prominent regulator of myocardial contractility. , 1996, Circulation research.
[19] S. Houser,et al. The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes. , 1999, Circulation research.
[20] P. Nicod,et al. The Thyroid and the Heart , 1993, Circulation.
[21] E. Morkin. Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.
[22] A. Toft,et al. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. , 1979, The American journal of cardiology.
[23] P. Foldes,et al. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. , 1997, The Journal of thoracic and cardiovascular surgery.
[24] P. Allenby,et al. Congestive heart failure and sudden death in a young woman with thyrotoxicosis. , 1988, The Western journal of medicine.
[25] S. Olsson,et al. Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. , 2009, Acta medica Scandinavica.
[26] J. Izzo,et al. Ca2+-induced Ca2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[27] I. Klein,et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. , 1996, The Annals of thoracic surgery.
[28] R. Segal,et al. Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.
[29] K. Hryniewicz,et al. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. , 2002, Thyroid : official journal of the American Thyroid Association.
[30] Mathew R. Williams,et al. Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.
[31] S. Mariotti,et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. , 2000, The Journal of clinical endocrinology and metabolism.
[32] B. Weintraub,et al. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". , 1991, The Annals of thoracic surgery.
[33] A. Toft,et al. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.
[34] B. Biondi,et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.
[35] I. Klein,et al. Thyroid hormone and the cardiovascular system. , 1990, The American journal of medicine.
[36] É. Kiss,et al. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.
[37] I. Klein,et al. Thyrotoxicosis and the heart. , 1998, Endocrinology and metabolism clinics of North America.
[38] J S Child,et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.
[39] P. Petersen,et al. Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.
[40] I. Klein,et al. Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children. , 1999, The American journal of cardiology.
[41] M. Lazar,et al. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. , 1990, The Journal of clinical investigation.
[42] I. Klein,et al. Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.
[43] I. Klein,et al. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. , 2000, Metabolism: clinical and experimental.
[44] H. Lindberg,et al. Depressed thyroid function following paediatric cardiopulmonary bypass: association with interleukin-6 release? , 1996, Scandinavian journal of thoracic and cardiovascular surgery.
[45] A. Pezzarossa,et al. Power spectral analysis of heart rate in hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.
[46] A. Hofman,et al. Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.
[47] M. Luu,et al. Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.
[48] T. Visser,et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. , 1996, Endocrinology.
[49] A. Samarel,et al. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. , 1992, The American journal of physiology.
[50] D. Iannone. [The cardiovascular system in hypothyroidism]. , 1967, Il Policlinico. Sezione pratica.
[51] W. Wiersinga. Amiodarone and the thyroid , 1997 .
[52] I. Klein,et al. Acute effects of thyroid hormone on vascular smooth muscle. , 1996, Thyroid : official journal of the American Thyroid Association.
[53] J. Franklyn,et al. Thyroid status in patients after acute myocardial infarction. , 1984, Clinical science.
[54] J. Patterson,et al. MECHANISM OF CERTAIN ABNORMALITIES OF THE CIRCULATION TO THE LIMBS IN THYROTOXICOSIS. , 1965, The Journal of clinical investigation.
[55] P. Trzepacz,et al. Hyperthyroid myopathy and the response to treatment. , 1991, Thyroid : official journal of the American Thyroid Association.
[56] F. Bogazzi,et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.
[57] N. Ishikawa,et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.
[58] P. Sótonyi,et al. Cardiac nuclear hormone receptor mRNA in heart failure in man. , 1996, Life sciences.
[59] K. Harjai,et al. Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.
[60] S. Liggett,et al. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.
[61] T. Parkin,et al. Treatment of heart disease associated with myxedema. , 1961, Progress in cardiovascular diseases.
[62] R. Mainwaring,et al. Reduction in Triiodothyronine Levels Following Modified Fontan Procedure , 1994, Journal of cardiac surgery.
[63] K. Ojamaa,et al. Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. , 1997, American journal of physiology. Endocrinology and metabolism.
[64] Robert W. Anderson,et al. Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial , 1996 .
[65] W F Bluhm,et al. Overexpression of sarcoplasmic reticulum Ca(2+)-ATPase improves cardiac contractile function in hypothyroid mice. , 1999, Cardiovascular research.
[66] Jennifer D. Walker,et al. The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. , 1994, The Journal of thoracic and cardiovascular surgery.
[67] S. Thomas,et al. Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.
[68] R. Mainwaring,et al. Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. , 2000, Circulation.
[69] I. Klein,et al. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. , 1990, The American journal of medicine.
[70] I. Klein,et al. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. , 2000, Endocrinology.
[71] E. O. Theilen,et al. Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. , 1967, Journal of applied physiology.
[72] F. Ismail-Beigi,et al. Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of α2 activity and mRNA abundance , 1990, The Journal of Membrane Biology.
[73] E W Bough,et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. , 1977, The New England journal of medicine.
[74] M. Bettendorf,et al. Transient Secondary Hypothyroidism in Children after Cardiac Surgery , 1997, Pediatric Research.
[75] I. Klein,et al. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. , 1992, Endocrinology.
[76] S. Wieshammer,et al. Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. , 1989, Canadian journal of physiology and pharmacology.
[77] W. White,et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. , 1996, JAMA.
[78] G. Kahaly,et al. Cardiovascular hemodynamics and exercise tolerance in thyroid disease. , 2002, Thyroid : official journal of the American Thyroid Association.
[79] A. Samarel,et al. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. , 1996, Endocrinology.
[80] I. Grupp,et al. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. , 1998, Circulation research.
[81] T. Feldman,et al. Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. , 1986, Journal of the American College of Cardiology.
[82] J. Franklyn,et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.
[83] I. Klein,et al. Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .
[84] G. Sandler,et al. The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. , 1959, The Quarterly journal of medicine.
[85] I. Klein,et al. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.
[86] H. Nakazawa,et al. Hyperthyroidism and the management of atrial fibrillation. , 2002, Thyroid : official journal of the American Thyroid Association.
[87] J. Amico,et al. Clinical and chemical assessment of thyroid function during therapy with amiodarone. , 1984, Archives of internal medicine.
[88] P. Ladenson,et al. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[89] K. Ito,et al. Management of atrial fibrillation in the post-thyrotoxic state. , 1982, The American journal of medicine.
[90] W. Dillmann. Biochemical basis of thyroid hormone action in the heart. , 1990, The American journal of medicine.
[91] G. Rosenthal,et al. Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. , 2000, Journal of Thoracic and Cardiovascular Surgery.
[93] F. Sellke,et al. The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.
[94] L. J. Groot,et al. Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome , 1999 .
[95] M. Bettendorf,et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.
[96] S. Connolly,et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.
[97] J. Laragh,et al. PLasma renin activity in syndromes of thyroid hormone excess and deficiency. , 1982, Life sciences.
[98] J. Campbell,et al. A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. , 1959, The Journal of clinical investigation.